Company page

Sophia Genetics Sa

Sophia Genetics SA is a public company traded under the ticker SOPH in the American market. The company has a market capitalization of approximately $479.9 million. Sophia Genetics focuses on advancing data-driven medicine through its innovative genomic analysis platform.